Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,108,177
-
Share change
-
+11,692,964
-
Total reported value
-
$86,073,000
-
Put/Call ratio
-
151%
-
Price per share
-
$4.28
-
Number of holders
-
68
-
Value change
-
+$52,596,703
-
Number of buys
-
37
-
Number of sells
-
30
Institutional Holders of ENDOCYTE INC - COM (ECYT) as of Q4 2017
As of 31 Dec 2017,
ENDOCYTE INC - COM (ECYT) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,108,177 shares.
The largest 10 holders included
Partner Fund Management, L.P., RA CAPITAL MANAGEMENT, LLC, FMR LLC, D. E. Shaw & Co., Inc., Vanguard Group Inc, PERCEPTIVE ADVISORS LLC, BlackRock Inc., BAKER BROS. ADVISORS LP, CITADEL ADVISORS LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.